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Abstract The use of Vibrio cholerae as a secretory expression 
system for the expression of a mammalian protein, namely 
human growth hormone, under the control of the heat labile 
enterotoxin chain B signal sequence is reported. The protein is 
efficiently expressed and processed. The mature protein is 
exported to the periplasm after which it is secreted to the 
extracellular milieu. The expressed and secreted hGH actively 
binds to its receptor as established by its receptor binding 
activity. The biological activity of the protein is demonstrated in
s itro in a Nb2 proliferation assay. 
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expression of a decapeptide homologous to the E. coli heat 
labile enterotoxin A, fused to cholera toxin B chain [9]. How- 
ever, the secretory capacity of the Vibrio cholerae export ap- 
paratus has not yet been exploited for the expression of het- 
erologous mammalian proteins. 
In the present investigation, we demonstrate he use of Vi- 
brio cholerae for efficient expression and secretion of a hetero- 
logous mammalian protein - the human growth hormone 
(hGH). This is the first report dealing with expression of a 
mammalian protein in the Vibrio cholerae system. The ex- 
pressed protein is transported to the extracellular environment 
via a periplasmic intermediate and the biological activity of 
the recombinant protein is demonstrated in an in vitro Nb2 
cell proliferation assay. 
1. Introduction 2. Materials and methods 
A variety of prokaryotic systems have been used for the 
c ~pression of genetically engineered proteins. In E. coli, the 
Frototype prokaryotic organism, a protein can either accumu- 
late in the cytoplasm in a soluble form [1], aggregate into 
iasoluble cytoplasmic aggregates [2] or be exported across 
tae membrane to the periplasmic space [3-5]. Hence, the de- 
elopment of a prokaryotic secretory expression system in 
v,,hich a heterologous recombinant protein is secreted utilizing 
t ae natural secretory pathway of the host is of great interest. 
I'ibrio cholerae, an organism closely related to E. coli, secretes 
,,ome of its natural toxins to the medium [6]. The cholera 
tgxin chain B (CTB) and the heat labile enterotoxin chain B 
I LTB) of E. coli origin are expressed and efficiently secreted in 
Vibrio cholerae [6] whereas they are retained in the periplasmic 
~pace when expressed in E. coli. 
Expression of CTB in a mutant of Vibrio cholerae leads to 
~n accumulation of the CTB in the periplasm; the mutation 
raaps outside the toxin genes indicating that the secretory 
t,athway of the host system is being used for the secretion 
17]. When LT is expressed in such a strain, it is not secreted 
[~]. The potential of this system for secretory expression has 
been limited to the expression of homologous proteins of pro- 
aryotic origin. The system has also been used for secretory 
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2.1. Bacterial strains, plasmids and media 
Ampicillin, polymyxin B and kanamycin were purchased from Sig- 
ma Chemicals, USA, Gibco Laboratories, USA and Boehringer 
Mannheim, Germany, respectively. Bacto-tryptone, Bacto-yeast ex- 
tract and Bacto-agar were from Difco Laboratories, USA. All DNA 
restriction and modification enzymes were procured from New Eng- 
land BioLabs, USA and used as per their recommendations, Isopro- 
pyl-I~-D-thio-galactopyranoside (IPTG) was obtained from Boehringer 
Mannheim. E. coli strain HB101 was used for all transformation 
experiments. El Tor Vibrio cholerae JBK70 (A-B-) cells were kindly 
provided by Dr. M. Lewin. The plasmid ptrpcGH was a gift from Dr. 
M. Ikehara. E. coli cells harboring plasmid pMMB68 and plasmid 
pRK2013 ,~ere gifts from Dr. J. Holmgren and Dr. H. Das, respec- 
tively. Commercially available plasmid pUC18 was used. 
2.2. Construction of plasmid pGGhGH-E 
Convenient cloning sites were generated by PCR amplification 
using primers harboring SacI and HindlII sites at the 5' and the 3' 
ends of the cGH fragment, respectively. The construction of the plas- 
mid pGGhGH-E (Fig. 1) has been reported earlier [10]. The first 
amino acid of LTB was retained at the junction of the signal sequence 
and mature protein. The + 1 site in the mature protein is thus occupied 
by an Ala residue. E. coli HB101 cells were transformed and plasmid 
DNA was isolated according to standard protocols as described [11]. 
2.3. Conjugal transfer of the construct o El Tor Vibrio cholerae JBK70 
cells 
E. coli pGGhGH-E, JBK70 and E. coli pRK2013 cells were used as 
donor, recipient and helper strains, respectively. The donor, recipient 
and helper strains were grown for 12-14 h in Luria-Bertani (LB) 
medium supplemented with 50 pg/ml ampicillin, 50 unitstml polymyx- 
in B and 50 ~tg/ml kanamycin, respectively. The donor was subcul- 
tured in ampicillin free LB and grown for 3 h with gentle shaking. 100 
I11 of each culture was mixed in an Eppendorf tube and centrifuged at
10 000 rpm for 2 min. The pellet, consisting of all three different ypes 
of cells, was resuspended in 100 ~tl of fresh LB and deposited on an 
LB plate in a very small area. The plate was incubated at 37°C for 10 
h. The cells were scraped off and resuspended in 5 ml sterile normal 
saline. Serial dilutions were made and plated on LB plates upplemen- 
ted with 50 ~g/ml ampicillin and 50 units/ml polymyxin B. An elabo- 
rate set of positive and negative controls was plated including a neg- 
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ative control for conjugation i  the absence of the helper strain. The 
transconjugant V. cholerae cells harboring the plasmid coding for 
hGH were called VhGH-E cells. 
2.4. Induction of hGH and preparation of cellular fractions 
VhGH-E cells were grown for 10-12 h in LB medium with 50 ~g/ml 
ampicillin and 50 units/ml polymyxin B. Freshly subcultured 0.5 A600/ 
ml unit cells were induced with 1 mM IPTG solution for different time 
intervals. Periplasmic and cytoplasmic fractions were separated by 
osmotic shock [12]. 
Cell supernatant collected from harvested induced cells was treated 
with TCA at a resultant concentration of 25% for 5 min on ice fol- 
lowed by centrifugation at 6000 rpm at 4°C in a Sorvall SS34 rotor. 
The pellet thus obtained was washed twice with acetone, resuspended 
in 50 mM phosphate buffer (pH 7.2) and analyzed for the presence of 
hGH. 
2.5. Western immunoblot analysis of hGH expression 
The cellular fractions and the supernatant samples, processed as 
described, were electrophoresed on a 15% SDS-PAGE. The resolved 
proteins were electrotransferred onto a nitrocellulose membrane for 
10 h at 30 mA. The nonspecific sites were saturated by incubating the 
membrane in a 1% nonfat milk solution prepared in 50 mM PBS (pH 
7.2) for I h. The blot was then incubated with a goat anti-hGH 
polyclonal antiserum followed by an incubation with an anti-goat 
IgG HRPO conjugate. The membrane was washed thoroughly with 
PBS containing 0.05% Tween-20 between successive incubations. The 
immunoreactive bands were visualized using 4-chloro-l-naphthol. 
2.6. Receptor binding activity and radioimmunoassay of recombinant 
hGH 
A rat liver tissue membrane preparation was used as a source of 
hGH receptor. Crude plasma membrane fraction was prepared by the 
method of Yeko et al. [13] with minor modifications, hGH was iodi- 
nated as described by Fraker and Speek [14]. The receptor binding 
activity of recombinant hGH was analyzed in the radio receptor assay 
(RRA) by the method escribed earlier by Yeko et al. [13] with minor 
modifications. Radioimmunoassay (RIA) of recombinant hGH was 
performed by the method described by Sambrook et al. [11] with 
minor modifications. 
2.7. Biological activity of secretory hGH 
The Nb2 cell proliferation assay [15] was used to check the biolo- 
gical activity of recombinant hGH. The proliferation was monitored 
by using an MTT cytotoxic assay [16]. 
3. Results and discussion 
3.1. Expression of hGH in Vibrio cholerae 
The transconjugant clones were selected and the presence of 
the plasmid pGGhGH-E  was confirmed by plasmid DNA 
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Fig. 1. Structure of plasmid pGGhGH-E. Plasmid pGGhGH-E con- 
sisting of human growth hormone gene (hGH) under the control of 
tac promoter (tac P) and heat-labile nterotoxin chain B signal se- 
quence (ss). 
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Fig. 2. Analysis of hGH expression. Cell supernatant, periplasm, 
and total cell extracts of VhGH-E cells grown in the presence and 
the absence of IPTG were boiled with SDS-PAGE reducing sample 
buffer, electrophoresed on a 15% SDS-PAGE and electrotransferred 
onto a nitrocellulose membrane. The membrane was immunoblotted 
with anti-hGH polyclonal antiserum. Lanes 3, 5 and 7 are superna- 
tant, periplasmic and total cell extract of induced VhGH-E cells, re- 
spectively. Lanes 2, 4 and 6 are the corresponding fractions of unin- 
duced VhGH-E cells. Lane 1 corresponds to standard pituitary 
hGH preparations. The arrow on the right points towards the mi- 
gration of mature hGH. The migration of molecular weight markers 
(kDa) is shown on the left. 
isolation and analysis. VhGH-E cells were induced for 6 h for 
the expression of hGH as described. The immunoblot analysis 
of the cellular fractions and cell supernatant (Fig. 2) indicates 
that the E1 Tor Vibrio eholerae cells expressed hGH, exported 
it to the periplasmic fraction after processing and further se- 
creted it into the extracellular milieu. To our knowledge, this 
is the first report of expression of any mammalian protein in 
Vibrio cholerae. 
The total cell extract of the induced cells showed the pres- 
ence of processed hGH. No band corresponding to the un- 
processed protein (hGH along with the signal peptide) can be 
seen in the total cell extract (Fig. 2, lane 7). The antibody used 
for the detection of the recombinant protein is capable of 
recognizing the unprocessed protein (data not shown) indicat- 
ing that the processing of the protein is very efficient. 
It is observed that a fraction of the expressed protein was 
retained intracellularly in the periplasm (Fig. 2, lane 5) of the 
cells in addition to the secretory product (Fig. 2, lane 3). This 
indicates that the protein is probably secreted from a periplas- 
mic pool. A similar phenomenon has been reported in the case 
of secretory expression of proteins in Bacillus subtilis and also 
in the case of expression of LTB in Vibrio cholerae [6,17,18]. 
Proteins that are secreted with the help of the signal sequences 
follow the type II pathway of secretion and involve a peri- 
plasmic intermediate [19]. The protein is probably held tran- 
siently in the periplasm. In Vibrio cholerae the secretion of the 
processed protein can be detected in the cell supernatant. The 
construct, pGGhGH-E,  when induced for the expression of 
the protein in E. coli, however, can only export the protein to 
the periplasmic space and no protein can be detected in the 
supernatant in E. coli [10]. This shows that the heat labile 
enterotoxin chain B signal sequence can mediate secretion of 
the protein in the medium only in V. eholerae and not in E. 
coli. It also suggests that Vibrio cholerae has a secretory ap- 
paratus which is absent in E. coli and probably it is this 
secretory apparatus that mediates the secretion of the hetero- 
logous proteins. 
3.2. Kinetics of hGH expression 
VhGH-E cells were induced with IPTG and samples were 
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tig. 3. Time course of hGH expression. The cell supernatant of the 
\hGH-E cells induced with 1 mM IPTG was harvested and the 
t'~oteins were precipitated with TCA as described. Equal volumes of 
stpernatant were mixed with reducing SDS-PAGE sample buffer 
aad analyzed as discussed. Lanes 2-6 represent cells withdrawn at 
( 0.5, 2, 4 and 8 h, respectively. Lane 1 represents standard pitui- 
t,~ry hGH preparation. The arrow on the right indicates the migra- 
ton of mature hGH. The migration of the molecular weight mar- 
I, ers (kDa) is shown on the left. 
drawn at time points 0-8 h. The supernatants were analyzed 
t.)r the expression of hGH (Fig. 3) and secretory hGH could 
le  detected by immunoblotting. The levels of secretory hGH 
iacrease with time and hGH can be detected until 8 h post 
iqduction indicating that the cells are actively secreting the 
recombinant protein in the late phases of growth as well. 
• '~berrant secretion of hGH has been reported in Bacillus sub- 
, 'lis where in the early phases of secretion, a reduced mobility 
land  corresponding to the unprocessed protein is detected in 
tae supernatant [20]. In Vibrio cholerae, however, only the 
i rocessed form of the protein, devoid of the signal sequence, 
; detected in the supernatant (Figs. 2 and 3). Absence of a 
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t ig. 4. Correlation between immunological activity and receptor 
binding activity of recombinant hGH. The periplasmic fractions of 
IPTG induced VhGH-E cells prepared from a constant number of 
cells at different ime points were analyzed for a comparative quan- 
t tation in an RIA and an RRA. 
< 
1.0 
0.9 
0.8 
0.7 
,~ 0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
0.0 
0.0001 
i /__1,q:i: 
/ 10.'+ 
" I "~ t o.3 R °.2 
o.I 
I I 1 I I 0 .0  
o,o o,2 o.+ 0.6 0,°  I,o 
Standard he l l  (r,,eJml) .j.S"-. 
I I I I I 
0.001 0.01 0.1 I 10 
Relative concentrations of cell supematants 
Fig. 5. Biological activity of secretory hGH. VhGH-E cells were in- 
duced with 1 mM IPTG. Cell supernatant was harvested, concen- 
trated and used as a source of recombinant hGH. Uninduced 
VhGH-E and induced V. cholerae JBK70-68 cells were used as neg- 
ative controls. Closed and open circles represent induced and unin- 
duced VhGH-E cells, respectively. Closed squares represent induced 
JBK70-68 cells. The inset shows Nb2 cell proliferation in the pres- 
ence of standard hGH. 
band corresponding to the unprocessed protein in the cells at 
any time point during induction suggests that the rate of 
processing of the protein is equivalent o or more than the 
rate of induction of expression. 
Prior to induction, there is no hGH present in the cells (Fig. 
2). However, the cells harvested immediately after the addi- 
tion of the inducer exhibit a band corresponding to the pro- 
cessed protein in the supernatant fraction of cells indicating 
that the induction of expression is very efficient (Fig. 3, lane 
2). With progressive induction, the amount of protein secreted 
in the medium showed a concomitant increase further con- 
firming that the protein is being expressed, processed and 
secreted in the medium continuously. 
3.3. Receptor binding activity of the recombinant hGH and 
radioimmunoassay 
For the receptor binding activity and radioimmunoassay of 
recombinant hGH, fractions of induced Vibrio cholerae cells 
were used. The RRA and RIA were used for quantification of 
recombinant hGH in periplasmic fractions (Fig. 4). The levels 
of hGH as quantitated increase during the time course of 
induction. Quantitation of the levels by both the assays gave 
14 I.tg/ml of hGH at 3 h post induction. The patterns of in- 
hibition obtained in both the assays indicate that recombinant 
hGH is recognized with an affinity equal to standard hGH by 
both anti-hGH antibodies and the hGH receptor. 
3.4. Biological activity of secretory hGH 
Cell supernatant of induced VhGH-E cells was tested for its 
ability to induce Nb2 cell proliferation in vitro (Fig. 5). Super- 
natants from uninduced VhGH-E cells and induced JBK70 
cells were used as controls. Supernatant from induced 
VhGH-E cells alone could induce cell proliferation. This in- 
dicated that the secretory hGH is biologically active. As 
170 
supernatant from uninduced cells is unable to induce prolif- 
eration, it also consolidates the observation of a stringent 
control on inducibility noted earlier from immunoblots. 
Thus, the use of Vibrio cholerae as a secretory system for 
the expression of a heterologous mammalian protein, namely 
human growth hormone, is demonstrated in this report for the 
first time. This system has the potential to be developed as an 
efficient secretory system of expression for a variety of other 
heterologous proteins. Availability of such a system will be 
critical to obtain recombinant product for direct structural 
and functional studies. 
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